Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ajit Harishkumar Goenka

12PUBLICATIONS
50CO-AUTHORS
Radiation therapyPredictive and prognostic markersCell physiologyCancer diagnosisContext learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

Sort by Publication Date:
|Jun 01, 2026
Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial.

|Apr 28, 2026
Next-generation AI for visually occult pancreatic cancer detection in a low-prevalence setting with longitudinal stability and multi-institutional generalisability.

|Nov 05, 2025
Interpretive consistency of a qualitative <sup>68</sup>Ga-PSMA PET framework for treatment response assessment in hepatocellular carcinoma: a head-to-head comparison with cross-sectional imaging.

Ajith Antony, Nguyen H Tran, Nandakumar G Patnam

|Oct 16, 2025
Crohn Disease Strictures: Multimodality Imaging to Identify Imaging Biomarkers.

Safa Hoodeshenas, Jonathan R Dillman, Stuart A Taylor

|Jan 04, 2024
Assessing the robustness of a machine-learning model for early detection of pancreatic adenocarcinoma (PDA): evaluating resilience to variations in image acquisition and radiomics workflow using image perturbation methods.

Sovanlal Mukherjee, Panagiotis Korfiatis, Nandakumar G Patnam

|Nov 27, 2023
Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol.

Aashna Karbhari, Sherly Mosessian, Kamaxi H Trivedi

Pageof 2

Frequent Collaborators

3 joint publications

David H Bruining

3 joint publications

Joel G Fletcher

2 joint publications

Shannon P Sheedy

1 joint publications

Sarasa Kim

1 joint publications

Roy Marcus

1 joint publications

Stephanie L Hansel

1 joint publications

John M Barlow

1 joint publications

Rickey E Carter

1 joint publications

Matthew P Johnson

1 joint publications

Jeff L Fidler

Frequent Collaborators

3 joint publications

David H Bruining

3 joint publications

Joel G Fletcher

2 joint publications

Shannon P Sheedy

1 joint publications

Sarasa Kim